SKP2 drives the sensitivity to neddylation inhibitors and cisplatin in malignant pleural mesothelioma

Overview of attention for article published in Journal of Experimental & Clinical Cancer Research, February 2022

Altmetric Badge

Mentioned by

twitter: 2 X users

Citations

dimensions_citation: 9 Dimensions

Readers on

mendeley: 12 Mendeley

Summary X Dimensions citations

So far, Altmetric has seen 3 X posts from 2 X users, with an upper bound of 2,245 followers.

RT @JournalofExper1: Published ✅ 𝐒𝐊𝐏𝟐 𝐝𝐫𝐢𝐯𝐞𝐬 𝐭𝐡𝐞 𝐬𝐞𝐧𝐬𝐢𝐭𝐢𝐯𝐢𝐭𝐲 𝐭𝐨 #𝐧𝐞𝐝𝐝𝐲𝐥𝐚𝐭𝐢𝐨𝐧 𝐢𝐧𝐡𝐢𝐛𝐢𝐭𝐨𝐫𝐬 𝐚𝐧𝐝 𝐜𝐢𝐬𝐩𝐥𝐚𝐭𝐢𝐧 𝐢𝐧 𝐦𝐚𝐥𝐢𝐠𝐧𝐚𝐧𝐭 𝐩𝐥𝐞𝐮𝐫𝐚𝐥 #𝐦𝐞𝐬𝐨𝐭𝐡𝐞𝐥𝐢𝐨𝐦𝐚…

Reply Repost Favourite

𝐒𝐊𝐏𝟐 𝐝𝐫𝐢𝐯𝐞𝐬 𝐭𝐡𝐞 𝐬𝐞𝐧𝐬𝐢𝐭𝐢𝐯𝐢𝐭𝐲 𝐭𝐨 #𝐧𝐞𝐝𝐝𝐲𝐥𝐚𝐭𝐢𝐨𝐧 𝐢𝐧𝐡𝐢𝐛𝐢𝐭𝐨𝐫𝐬 𝐚𝐧𝐝 𝐜𝐢𝐬𝐩𝐥𝐚𝐭𝐢𝐧 𝐢𝐧 𝐦𝐚𝐥𝐢𝐠𝐧𝐚𝐧𝐭 𝐩𝐥𝐞𝐮𝐫𝐚𝐥 #𝐦𝐞𝐬𝐨𝐭𝐡𝐞𝐥𝐢𝐨𝐦𝐚

Reply Repost Favourite

Published ✅ 𝐒𝐊𝐏𝟐 𝐝𝐫𝐢𝐯𝐞𝐬 𝐭𝐡𝐞 𝐬𝐞𝐧𝐬𝐢𝐭𝐢𝐯𝐢𝐭𝐲 𝐭𝐨 #𝐧𝐞𝐝𝐝𝐲𝐥𝐚𝐭𝐢𝐨𝐧 𝐢𝐧𝐡𝐢𝐛𝐢𝐭𝐨𝐫𝐬 𝐚𝐧𝐝 𝐜𝐢𝐬𝐩𝐥𝐚𝐭𝐢𝐧 𝐢𝐧 𝐦𝐚𝐥𝐢𝐠𝐧𝐚𝐧𝐭 𝐩𝐥𝐞𝐮𝐫𝐚𝐥 #𝐦𝐞𝐬𝐨𝐭𝐡𝐞𝐥𝐢𝐨𝐦𝐚 For free 👇 https://t.co/D6W1SXVHrj #ERstress @IREISGufficiale https://t.co/ssvOY1YgA5

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity.